Richard Whitley to Infant
This is a "connection" page, showing publications Richard Whitley has written about Infant.
Connection Strength
0.817
-
Global assessment of resistance to neuraminidase inhibitors, 2008-2011: the Influenza Resistance Information Study (IRIS). Clin Infect Dis. 2013 May; 56(9):1197-205.
Score: 0.070
-
Treatment of herpes simplex virus infections in pediatric patients: current status and future needs. Clin Pharmacol Ther. 2010 Nov; 88(5):720-4.
Score: 0.060
-
Treatment of congenital cytomegalovirus infection: implications for future therapeutic strategies. J Antimicrob Chemother. 2009 May; 63(5):862-7.
Score: 0.054
-
Therapy of herpes virus infections in children. Adv Exp Med Biol. 2008; 609:216-32.
Score: 0.049
-
Prevention and treatment of influenza in high-risk groups: children, pregnant women, immunocompromised hosts, and nursing home residents. J Infect Dis. 2006 Nov 01; 194 Suppl 2:S133-8.
Score: 0.046
-
Herpes simplex encephalitis: adolescents and adults. Antiviral Res. 2006 Sep; 71(2-3):141-8.
Score: 0.044
-
Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004 Nov 01; 39(9):1267-84.
Score: 0.039
-
Congenital cytomegalovirus infection: epidemiology and treatment. Adv Exp Med Biol. 2004; 549:155-60.
Score: 0.037
-
Herpes simplex virus infection. Semin Pediatr Infect Dis. 2002 Jan; 13(1):6-11.
Score: 0.033
-
Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J. 2001 Feb; 20(2):127-33.
Score: 0.031
-
Viral encephalitis. Pediatr Rev. 1999 Jun; 20(6):192-8.
Score: 0.027
-
Human herpesvirus 6 is associated with focal encephalitis. Clin Infect Dis. 1995 Sep; 21(3):571-6.
Score: 0.021
-
A Randomized, Double-Blind, Placebo-Controlled Trial of Pleconaril for the Treatment of Neonates With Enterovirus Sepsis. J Pediatric Infect Dis Soc. 2016 Mar; 5(1):53-62.
Score: 0.020
-
Herpes simplex virus infections of the central nervous system: therapeutic and diagnostic considerations. Clin Infect Dis. 1995 Feb; 20(2):414-20.
Score: 0.020
-
The posology of oseltamivir in infants with influenza infection using a population pharmacokinetic approach. Clin Pharmacol Ther. 2014 Sep; 96(3):380-9.
Score: 0.019
-
Oseltamivir pharmacokinetics, dosing, and resistance among children aged <2 years with influenza. J Infect Dis. 2013 Mar 01; 207(5):709-20.
Score: 0.017
-
Correlation and clinical utility of pp65 antigenemia and quantitative polymerase chain reaction assays for detection of cytomegalovirus in pediatric renal transplant patients. Pediatr Transplant. 2012 Sep; 16(6):627-37.
Score: 0.017
-
Reference values in pediatric medicine. Mayo Clin Proc. 1990 Mar; 65(3):431-5.
Score: 0.014
-
Safety of oseltamivir compared with the adamantanes in children less than 12 months of age. Pediatr Infect Dis J. 2010 Mar; 29(3):195-8.
Score: 0.014
-
Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol. 2009 Dec; 46 Suppl 4:S22-6.
Score: 0.014
-
Herpes simplex virus infections of the central nervous system. A review. Am J Med. 1988 Aug 29; 85(2A):61-7.
Score: 0.013
-
Ganciclovir population pharmacokinetics in neonates following intravenous administration of ganciclovir and oral administration of a liquid valganciclovir formulation. Clin Pharmacol Ther. 2007 Jun; 81(6):867-72.
Score: 0.012
-
Approaches to therapy of viral infections. Adv Pediatr. 1987; 34:89-110.
Score: 0.012
-
Therapy of viral infections in children. Adv Pediatr Infect Dis. 1987; 2:35-56.
Score: 0.012
-
Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med. 1986 Jan 16; 314(3):144-9.
Score: 0.011
-
Detection of cytomegalovirus (CMV) DNA by polymerase chain reaction is associated with hearing loss in newborns with symptomatic congenital CMV infection involving the central nervous system. J Infect Dis. 2005 Jan 15; 191(2):227-33.
Score: 0.010
-
Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr. 2003 Jul; 143(1):16-25.
Score: 0.009
-
Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis. Pediatr Infect Dis J. 2003 Apr; 22(4):335-41.
Score: 0.009
-
Dna restriction-enzyme analysis of herpes simplex virus isolates obtained from patients with encephalitis. N Engl J Med. 1982 Oct 21; 307(17):1060-2.
Score: 0.009
-
Herpes simplex encephalitis. Clinical Assessment. JAMA. 1982 Jan 15; 247(3):317-20.
Score: 0.008
-
Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics. 2001 Aug; 108(2):223-9.
Score: 0.008
-
Clinical significance of enteroviruses in serious summer febrile illnesses of children. Pediatr Infect Dis J. 1999 Oct; 18(10):869-74.
Score: 0.007
-
Developmental aspects of adenine arabinoside for parenteral therapy of human herpesvirus infections. Adv Ophthalmol. 1979; 38:288-96.
Score: 0.007
-
Application of competitive PCR to cerebrospinal fluid samples from patients with herpes simplex encephalitis. J Clin Microbiol. 1998 Aug; 36(8):2229-34.
Score: 0.006
-
Diagnosis of enterovirus infection by polymerase chain reaction of multiple specimen types. Pediatr Infect Dis J. 1997 Apr; 16(4):409-11.
Score: 0.006
-
Protracted pneumonitis in young infants associated with perinatally acquired cytomegaloviral infection. J Pediatr. 1976 Jul; 89(1):16-22.
Score: 0.006
-
Therapy of herpetic infections in man: a status report. Adv Pathobiol. 1976; (5):159-72.
Score: 0.005
-
Rapid detection of herpes-simplex-virus DNA in cerebrospinal fluid of patients with herpes simplex encephalitis. Lancet. 1990 Feb 24; 335(8687):440-1.
Score: 0.004
-
Congenital cytomegalovirus: immunological alterations. J Med Virol. 1987 Sep; 23(1):41-9.
Score: 0.003
-
Infant pneumonitis associated with cytomegalovirus, Chlamydia, Pneumocystis, and Ureaplasma: follow-up. Pediatrics. 1987 Jan; 79(1):76-83.
Score: 0.003
-
Experience with brain biopsy for suspected herpes encephalitis: a review of forty consecutive cases. Neurosurgery. 1983 Jun; 12(6):654-7.
Score: 0.002
-
Herpes simplex virus encephalitis: laboratory evaluations and their diagnostic significance. J Infect Dis. 1982 Jun; 145(6):829-36.
Score: 0.002
-
Specific lymphocyte blastogenic responses in children with cytomegalovirus and herpes simplex virus infections acquired early in infancy. Infect Immun. 1981 Oct; 34(1):166-70.
Score: 0.002
-
Infant pneumonitis associated with cytomegalovirus, Chlamydia, Pneumocystis, and Ureaplasma: a prospective study. Pediatrics. 1981 Sep; 68(3):322-9.
Score: 0.002
-
Herpes zoster in early infancy. Am J Dis Child. 1980 Jun; 134(6):618-9.
Score: 0.002
-
Antiviral chemotherapy and neonatal herpes simplex virus infecition: a pilot study--experience with adenine arabinoside (ARA-A). Pediatrics. 1975 May; 55(5):678-85.
Score: 0.001
-
Effect of adenine arabinoside on cytomegalovirus infections. J Infect Dis. 1974 Jul; 130(1):32-9.
Score: 0.001